| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Heiq PLC
LSE:HEIQ
Heiq PLC
Cash & Cash Equivalents
Heiq PLC
Cash & Cash Equivalents Peer Comparison
JMAT
CRDA
VCT
ELM
SYNT
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
H
|
Heiq PLC
LSE:HEIQ
|
Cash & Cash Equivalents
$9.7m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
|
Johnson Matthey PLC
LSE:JMAT
|
Cash & Cash Equivalents
£542m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
|
Croda International PLC
LSE:CRDA
|
Cash & Cash Equivalents
£172.5m
|
CAGR 3-Years
17%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
Victrex PLC
LSE:VCT
|
Cash & Cash Equivalents
£28.5m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-10%
|
|
|
Elementis PLC
LSE:ELM
|
Cash & Cash Equivalents
$65.8m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
0%
|
|
|
Synthomer PLC
LSE:SYNT
|
Cash & Cash Equivalents
£371.3m
|
CAGR 3-Years
23%
|
CAGR 5-Years
31%
|
CAGR 10-Years
20%
|
See Also
What is Heiq PLC's Cash & Cash Equivalents?
Cash & Cash Equivalents
9.7m
USD
Based on the financial report for Dec 31, 2023, Heiq PLC's Cash & Cash Equivalents amounts to 9.7m USD.
What is Heiq PLC's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
35%
Over the last year, the Cash & Cash Equivalents growth was 14%. The average annual Cash & Cash Equivalents growth rates for Heiq PLC have been -28% over the past three years , 35% over the past five years .
You don't have any saved screeners yet
